Junshi Bio (01877) announced interim results
- RevenueRMB17.0bn
- Net profitRMB-37.0M
- Profit attributable to ownersRMB25.5M
- Revenue YoY+45.2%
- Net profit YoY+92.1%
- Depreciation & amortisationHK$2.8bn
- Capital expenditureHK$-7.7bn
- Interest-bearing debtHK$34.5bn
Source Junshi Bio



